Scarica l'app Stockscreener
22.02
8.86%
-2.14
Pre-mercato:
21.52
-0.50
-2.27%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny - MSN
Hims & Hers (HIMS) soars 10.3% on analyst upgrades, new deal - MSN
Hims & Hers (HIMS) tumbles 8.86% on market bloodbath, profit-taking - MSN
Hims & Hers (HIMS) Tumbles 8.86% on Market Bloodbath, Profit-Taking - Insider Monkey
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc.HIMS - Morningstar
Does Hims & Hers (HIMS) Novo Nordisk Deal Quietly Redraw Its Risk Reward Profile? - Yahoo Finance
Hims Says Failed Wegovy Collab Doesn't Merit Investor Suit - Law360
Hims & Hers stock falls as technical resistance weighs and buyers lose steam near $24 - Traders Union
Hims & Hers Elevates Technology-Driven Healthcare Accessibility - MSN
Investor relations - HIMS Investor Relations
Hims & Hers Health stock: Daily momentum and support levels drive a 3.41% advance - Traders Union
Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy - Benzinga
Buying pressure lifts Hims & Hers Health stock higher in today's trading - Traders Union
Understanding Momentum Shifts in (HIMS) - Stock Traders Daily
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
Hims & Hers Health, Inc. (HIMS) suffers a larger drop than the general market: Key insights - MSN
Insider Sell: Irene Becklund Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Hims & Hers Health Faces Another Legal Setback Amid Probes and Falling Shares - StocksToTrade
Insider Selling: Hims & Hers Health (NYSE:HIMS) COO Sells 97,289 Shares of Stock - MarketBeat
Hims & Hers Health (NYSE:HIMS) Insider Sells $136,511.01 in Stock - MarketBeat
Hims & Hers health COO Chi sells $2.4m in shares - Investing.com
Top Healthcare Stocks To Follow TodayMarch 18th - MarketBeat
Hims & Hers Opens Waitlist For $149 Branded Wegovy And Ozempic Via Novo Nordisk Deal - Benzinga
Hims & Hers Opens Up Pre-Launch Waitlist For Ozempic And Wegovy Following Partnership With Novo Nordisk - Stocktwits
Telemedicine company Hims & Hers Health Inc. (NYSE: HIMS) announced that its service platform will expand its product range to include Novo Nordisk's Wegovy® (semaglutide) oral tablets and injections, as well as Ozempic® injections. - Bitget
A New Era of Weight Management is Coming to Hims & Hers - Hims & Hers Newsroom
Greenfield Seitz Capital Management LLC Sells 43,334 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move - Yahoo Finance
Healthcare Stocks To ConsiderMarch 17th - MarketBeat
HIMS Stock: After a 57% Surge, Is It Time to Buy Hims & Hers? - CMC Markets
Hims & Hers Health shares see a dip — What is pressuring the stock - Traders Union
Hims & Hers Health, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Aquatic Capital Management LLC Purchases New Stake in Hims & Hers Health, Inc. $HIMS - MarketBeat
Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market - MSN
HIMS: Leerink Partners Raises Price Target to $25.00 | HIMS Stoc - GuruFocus
Hims & Hers Health (NYSE:HIMS) Price Target Raised to $25.00 at Leerink Partners - MarketBeat
Hims And Hers Health Pushes Into Complex Care And Global Growth - Yahoo Finance
HIMS Expands Personalized Digital Healthcare Access and Services - The Globe and Mail
Hims & Hers Health Stock Slips After Surging 50% In A Month - Benzinga
Novo Nordisk & Hims & Hers: Supply Deal for Ozempic and WegovyNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
What is behind Hims & Hers Health stock's recent drop in value today - Traders Union
Why the Novo Nordisk and Hims & Hers deal is a win for both stocks - MSN
Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks - Yahoo Finance
Farallon Capital Management LLC Purchases 2,533,271 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers under fire over copycat weight loss drugs - WNTZ-TV FOX 48
Hims & Hers Health (HIMS) Is Up 57.4% After Renewed Novo Nordisk GLP-1 PartnershipHas The Bull Case Changed? - simplywall.st
Hims & Hers Stock Soars on Strategic Pivot with Novo Nordisk - AD HOC NEWS
Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now? - Insider Monkey
Clear Street Group Inc. Invests $87.37 Million in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers (HIMS) Soars 57.4% on New Deal - Insider Monkey
A Look At Hims & Hers Health (HIMS) Valuation After A Sharp 57% Weekly Share Price Move - simplywall.st
Hims & Hers posts best weekly gain after Novo deal - Seeking Alpha
OWL, HIMS, TSLA And More: 5 Stocks Investors Couldn't Stop Buzzing About This WeekOracle (NYSE:ORCL) - Benzinga
Hims & Hers Health, Inc. Class A Trade Ideas — SWB:82W - TradingView
Telehealth Giant Hims Partners with Novo Nordisk After Dropping Legal Battle - Fine Day 102.3
Hims And Hers Health Weighs Eucalyptus Deal Against Growth And Valuation Risks - simplywall.st
Weekly Market Update: Stocks Slide as Financials, Consumer Cyclicals Fall - Morningstar
Hims & Hers Stock Skyrockets Amid Novo Nordisk Partnership - StocksToTrade
Hims Shares Notch Record Week as Novo Pact Spurs Optimism - Yahoo Finance
Hims & Hers (HIMS) sees analyst optimism following Novo resolution - MSN
Hims & Hers (HIMS) Sees Analyst Optimism Following Novo Resolution - Insider Monkey
Selling pressure pushes Hims & Hers Health stock lower in today's trading - Traders Union
Hims & Hers class action alleges semaglutide GLP-1 products falsely advertised - Class Action Lawsuits
Hims shares set for record week as Novo partnership fuels optimism - Modern Healthcare
Barclays Raises PT on Hims & Hers Health (HIMS) Stock - Insider Monkey
Hims & Hers Health stock price steadies after wild Novo week as focus shifts to margins - TechStock²
2.69%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):